ReviewJCO oncology practice2020

Patterns of Ruxolitinib Therapy Failure and Its Management in Myelofibrosis: Perspectives of the Canadian Myeloproliferative Neoplasm Group.

Vikas Gupta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.